BIARYL SUBSTITUTED HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION
申请人:Sandanayaka Vincent
公开号:US20070066820A1
公开(公告)日:2007-03-22
The present invention relates to a chemical genus of biaryl substituted heterocycle inhibitors of LTA4H (leukotriene A4 hydrolase) useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders. The compounds have general formula Ψ:
An example is
Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
作者:Douglas R. Davies、Bjorn Mamat、Olafur T. Magnusson、Jeff Christensen、Magnus H. Haraldsson、Rama Mishra、Brian Pease、Erik Hansen、Jasbir Singh、David Zembower、Hidong Kim、Alex S. Kiselyov、Alex B. Burgin、Mark E. Gurney、Lance J. Stewart
DOI:10.1021/jm900259h
日期:2009.8.13
FOL library against leukotrieneA4hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis